Trump’s tariff threat: Impact on drug costs
In a decision that may alter international trade patterns, ex-President Donald Trump indicated his plan to eliminate tariff waivers for pharmaceutical goods. This declaration has created apprehension among industry executives and global allies, since such an action could greatly affect the price and accessibility of vital medications globally.The pharmaceutical industry, which relies heavily on global supply chains, has benefited from longstanding trade agreements that allow many drugs and raw materials to move across borders without additional taxes. These exemptions have been crucial in maintaining competitive pricing and ensuring consistent access to life-saving treatments. However, Trump's rhetoric suggests a shift in…